Case Control Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Sep 7, 2022; 28(33): 4812-4822
Published online Sep 7, 2022. doi: 10.3748/wjg.v28.i33.4812
Table 3 The results of special examination of subjects with pancreatic ductal adenocarcinoma
No.SexAge in yrBlood samples
Pancreatic tissue
HBsAg
Anti-HBc
Anti-HBs
HBV DNA, IU/mL
HBV DNA, IU/mL
pgRNA HBV, IU/mL
cccDNA, copies/cell × 10-6
HBxAg
HBx-positive cells1, %
1M50NegPosNegTnd653Tnd257Pos3.9
2F58NegPosPosTnd4157971440NpNp
3M60NegPosPosTnd1183TndTndPos3.7
4M61NegPosPosTnd364520314Pos3.4
5F63NegPosPosTndTndTndTndNeg0
6F66NegPosPos134868NpNpNpNp
7M69NegPosPosTnd610TndTndNpNp
8M69NegPosPosTnd30214281384NpNp
9F70NegPosPos126834Tnd1026Pos9.9